Randomised Controlled Trial of the Effects of Kefir on Behaviour, Sleep and the Microbiome in Children with ADHD: a Study Protocol

Overview

Journal BMJ Open

Specialty General Medicine

Date 2023 Dec 27

PMID 38149413

Authors

Kate Lawrence

Philippa Fibert

Jemima Hobbs

Kyriaki Myrissa

Miguel A Toribio-Mateas

Frits Quadt

Paul D Cotter

Alice M Gregory

Affiliations

Soon will be listed here.

Abstract

Introduction: Current interventions for children with attention-deficit/hyperactivity disorder (ADHD) are primarily medication, behavioural therapy and parent training. However, research suggests dietary manipulations may provide therapeutic benefit for some. There is accumulating evidence that the gut microbiome may be atypical in ADHD, and therefore, manipulating gut bacteria in such individuals may help alleviate some of the symptoms of this condition. The aim of this study is to explore the effects of supplementation with kefir (a fermented dairy drink) on ADHD symptomatology, sleep, attention and the gut microbiome in children diagnosed with ADHD.

Methods And Analysis: A 6-week randomised, double-blind, placebo-controlled trial in 70 children aged 8-13 years diagnosed with ADHD. Participants will be recruited throughout the UK, through support groups, community groups, schools, social media and word of mouth. Children will be randomised to consume daily either dairy kefir or a placebo dairy drink for 6 weeks. The primary outcome, ADHD symptomatology, will be measured by The Strengths and Weakness of ADHD-symptoms and Normal-behaviour scale. Secondary outcomes will include gut microbiota composition (using shotgun metagenomic microbiome sequencing), gut symptomatology (The Gastrointestinal Severity Index questionnaire), sleep (using 7-day actigraphy recordings, The Child's Sleep Habits Questionnaire and Sleep Self Report questionnaire), inattention and impulsivity (with a computerised Go/NoGo test). Assessments will be conducted prior to the intervention and at the end of the intervention. Interaction between time (preintervention/postintervention) and group (probiotic/placebo) is to be analysed using a Mixed Model Analysis of Variances.

Ethics And Dissemination: Ethical approval for the study was granted by St Mary's University Ethics Committee. Results will be disseminated through peer-reviewed publications, presentations to the scientific community and support groups.

Trial Registration Number: NCT05155696.

References

Mohammadi M, Mostafavi S, Keshavarz S, Eshraghian M, Hosseinzadeh P, Hosseinzadeh-Attar M . Melatonin effects in methylphenidate treated children with attention deficit hyperactivity disorder: a randomized double blind clinical trial. Iran J Psychiatry. 2012; 7(2):87-92. PMC: 3428643. View

Chifiriuc M, Cioaca A, Lazar V . In vitro assay of the antimicrobial activity of kephir against bacterial and fungal strains. Anaerobe. 2011; 17(6):433-5. DOI: 10.1016/j.anaerobe.2011.04.020. View

Storebo O, Ramstad E, Krogh H, Nilausen T, Skoog M, Holmskov M . Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Cochrane Database Syst Rev. 2015; (11):CD009885. PMC: 8763351. DOI: 10.1002/14651858.CD009885.pub2. View

Owens J, Maxim R, Nobile C, McGuinn M, Msall M . Parental and self-report of sleep in children with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med. 2000; 154(6):549-55. DOI: 10.1001/archpedi.154.6.549. View

Denis D, Eley T, Rijsdijk F, Zavos H, Keers R, Espie C . Is digital cognitive behavioural therapy for insomnia effective in treating sub-threshold insomnia: a pilot RCT. Sleep Med. 2020; 66:174-183. DOI: 10.1016/j.sleep.2019.10.007. View

Carney C, Buysse D, Ancoli-Israel S, Edinger J, Krystal A, Lichstein K . The consensus sleep diary: standardizing prospective sleep self-monitoring. Sleep. 2012; 35(2):287-302. PMC: 3250369. DOI: 10.5665/sleep.1642. View

Hsu Y, Huang W, Lin J, Chen Y, Ho S, Huang C . Kefir Supplementation Modifies Gut Microbiota Composition, Reduces Physical Fatigue, and Improves Exercise Performance in Mice. Nutrients. 2018; 10(7). PMC: 6073576. DOI: 10.3390/nu10070862. View

Sonuga-Barke E, Brandeis D, Cortese S, Daley D, Ferrin M, Holtmann M . Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am J Psychiatry. 2013; 170(3):275-89. DOI: 10.1176/appi.ajp.2012.12070991. View

Bull-Larsen S, Mohajeri M . The Potential Influence of the Bacterial Microbiome on the Development and Progression of ADHD. Nutrients. 2019; 11(11). PMC: 6893446. DOI: 10.3390/nu11112805. View

10.

Horowitz I, Avirame K, Naim-Feil J, Rubinson M, Moses E, Gothelf D . The interactive effects of test-retest and methylphenidate administration on cognitive performance in youth with ADHD: A double-blind placebo-controlled crossover study. Psychiatry Res. 2020; 291:113056. DOI: 10.1016/j.psychres.2020.113056. View

11.

Suresh K . An overview of randomization techniques: An unbiased assessment of outcome in clinical research. J Hum Reprod Sci. 2011; 4(1):8-11. PMC: 3136079. DOI: 10.4103/0974-1208.82352. View

12.

Bellikci-Koyu E, Sarer-Yurekli B, Akyon Y, Aydin-Kose F, Karagozlu C, Ozgen A . Effects of Regular Kefir Consumption on Gut Microbiota in Patients with Metabolic Syndrome: A Parallel-Group, Randomized, Controlled Study. Nutrients. 2019; 11(9). PMC: 6769690. DOI: 10.3390/nu11092089. View

13.

Howard A, Robinson M, Smith G, Ambrosini G, Piek J, Oddy W . ADHD is associated with a "Western" dietary pattern in adolescents. J Atten Disord. 2010; 15(5):403-11. DOI: 10.1177/1087054710365990. View

14.

Puri B, Martins J . Which polyunsaturated fatty acids are active in children with attention-deficit hyperactivity disorder receiving PUFA supplementation? A fatty acid validated meta-regression analysis of randomized controlled trials. Prostaglandins Leukot Essent Fatty Acids. 2014; 90(5):179-89. DOI: 10.1016/j.plefa.2014.01.004. View

15.

Polderman T, Derks E, Hudziak J, Verhulst F, Posthuma D, Boomsma D . Across the continuum of attention skills: a twin study of the SWAN ADHD rating scale. J Child Psychol Psychiatry. 2007; 48(11):1080-7. DOI: 10.1111/j.1469-7610.2007.01783.x. View

16.

Nigg J, Lewis K, Edinger T, Falk M . Meta-analysis of attention-deficit/hyperactivity disorder or attention-deficit/hyperactivity disorder symptoms, restriction diet, and synthetic food color additives. J Am Acad Child Adolesc Psychiatry. 2011; 51(1):86-97.e8. PMC: 4321798. DOI: 10.1016/j.jaac.2011.10.015. View

17.

Bendz L, Scates A . Melatonin treatment for insomnia in pediatric patients with attention-deficit/hyperactivity disorder. Ann Pharmacother. 2009; 44(1):185-91. DOI: 10.1345/aph.1M365. View

18.

Swanson J, Schuck S, Porter M, Carlson C, Hartman C, Sergeant J . Categorical and Dimensional Definitions and Evaluations of Symptoms of ADHD: History of the SNAP and the SWAN Rating Scales. Int J Educ Psychol Assess. 2015; 10(1):51-70. PMC: 4618695. View

19.

Beghini F, McIver L, Blanco-Miguez A, Dubois L, Asnicar F, Maharjan S . Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3. Elife. 2021; 10. PMC: 8096432. DOI: 10.7554/eLife.65088. View

20.

Prehn-Kristensen A, Zimmermann A, Tittmann L, Lieb W, Schreiber S, Baving L . Reduced microbiome alpha diversity in young patients with ADHD. PLoS One. 2018; 13(7):e0200728. PMC: 6042771. DOI: 10.1371/journal.pone.0200728. View